162. 類天疱瘡（後天性表皮水疱症を含む。） Pemphigoid Clinical trials / Disease details

臨床試験数 : 90 / 薬物数 : 122 - (DrugBank : 47) / 標的遺伝子数 : 34 - 標的パスウェイ数 : 144

1 trial found

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2018-002564-10-NL (EUCTR)	23/04/2019	23/04/2019	PDE4 inhibitor (apremilast) in pemphigoid.	Short-term safety, efficacy and mode of action of apremilastin mild to moderate cutaneous pemphigoid ...	Pemphigoid;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]	Trade Name: Otezla Product Name: Apremilast Product Code: CC -10004	Universitair Medisch Centrum Groningen	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	10	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - ( ...	Netherlands

First Previous1Next Last